Iovance Biotherapeutics
IOVA
IOVA
82 hedge funds and large institutions have $357M invested in Iovance Biotherapeutics in 2016 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 39 increasing their positions, 18 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
6% more funds holding
Funds holding: 77 → 82 (+5)
91% less call options, than puts
Call options by funds: $841K | Put options by funds: $9.37M
Holders
82
Holding in Top 10
5
Calls
$841K
Puts
$9.37M
Top Buyers
| 1 | +$19.1M | |
| 2 | +$9.83M | |
| 3 | +$9.46M | |
| 4 |
BC
Broadfin Capital
New York
|
+$8.63M |
| 5 |
PA
Perceptive Advisors
New York
|
+$6.68M |
Top Sellers
| 1 | -$5.42M | |
| 2 | -$3.89M | |
| 3 | -$1.58M | |
| 4 |
NC
Nexthera Capital
New York
|
-$774K |
| 5 |
VIA
Vident Investment Advisory
Alpharetta,
Georgia
|
-$737K |